BioCorRx Price To Earning vs. Net Income

Please note, there is a significant difference between BioCorRx's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioCorRx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioCorRx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BioCorRx Net Income vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BioCorRx's current stock value. Our valuation model uses many indicators to compare BioCorRx value to that of its competitors to determine the firm's financial worth.
BioCorRx is number one stock in price to earning category among its peers. It is rated third in net income category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioCorRx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioCorRx's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

BioCorRx Net Income vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

BioCorRx

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
3.61 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

BioCorRx

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(5.21 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

BioCorRx Net Income Comparison

BioCorRx is currently under evaluation in net income category among its peers.

BioCorRx Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BioCorRx, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioCorRx will eventually generate negative long term returns. The profitability progress is the general direction of BioCorRx's change in net profit over the period of time. It can combine multiple indicators of BioCorRx, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.

BioCorRx Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BioCorRx. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioCorRx position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioCorRx's important profitability drivers and their relationship over time.

BioCorRx Earnings per Share Projection vs Actual

Use BioCorRx in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioCorRx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCorRx will appreciate offsetting losses from the drop in the long position's value.

BioCorRx Pair Trading

BioCorRx Pair Trading Analysis

The ability to find closely correlated positions to BioCorRx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioCorRx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioCorRx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioCorRx to buy it.
The correlation of BioCorRx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioCorRx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioCorRx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioCorRx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BioCorRx position

In addition to having BioCorRx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Convertibles Funds Thematic Idea Now

Convertibles Funds
Convertibles Funds Theme
Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles Funds theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for BioCorRx OTC Stock Analysis

When running BioCorRx's price analysis, check to measure BioCorRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCorRx is operating at the current time. Most of BioCorRx's value examination focuses on studying past and present price action to predict the probability of BioCorRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCorRx's price. Additionally, you may evaluate how the addition of BioCorRx to your portfolios can decrease your overall portfolio volatility.